NL-OMON31759已完成不适用
Sensing With Insulin Pump Therapy to Control HbA1c - Sensing With Insulin Pump Therapy to Control HbA1c
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •*Type 1 diabetes mellitus diagnosed for at least 12 months prior to signature of informed consent,
- •*Sub-optimal glycemic control (7.5%*Patient treated by continuous subcutaneous insulin infusion (CSII) for at least 6 months prior signature of informed consent.
- •*Patient treated within the practice of the investigator*s center at least 6 months prior signature of informed consent.
- •*Patient has no preliminary experience with the sensor function of the PRT or the Guardian® REAL-Time for the 4 months prior signature of informed consent.
排除标准
- •Existing pregnancy or intention to conceive (as assessed by investigator).
- •*Hearing or vision impairment so that glucose display and alarms cannot be recognized.
- •*Three or more incidents in the last 12 months of severe hypoglycaemia with documented BG below 50mg/dL (if possible), resulting in unconsciousness, hospitalisation or third party assistance, where recovery follows treatment with glucose or glucagon or similar.
研究者
相似试验
进行中（未招募）
不适用
Insulin Therapy in non-diabetic patients with Acute Coronary Syndromes: Effect of strict glycemic control on systemic endothelial function, coronary flow reserve, and left ventricular contractility - ITACASIperglycemia with Acute Coronary SyndromeMedDRA version: 9.1Level: LLTClassification code 10051592Term: Acute coronary syndromeEUCTR2007-003906-89-ITIstituto Fisiologia Clinica, CNR
撤回
2 期
Insulin Pump therapy for Reducing Diabetic complications (InsPyReD) studyNeurological - Neurodegenerative diseasesMetabolic and Endocrine - DiabetesEye - Diseases / disorders of the eyeDiabetic NeuropathyType 1 diabetesDiabetesACTRN12617000124336niversity of New South Wales Australia60
进行中（未招募）
不适用
Subcutaneous insulin therapy of hyperglycemia after initiation of oral intake in the ICHyperglycemia is very common in hospitalized, critically ill patients and is associated with higher mortality and morbidity. Careful monitoring and therapy of hyperglycemia have become standard in the ICU. Therapy of hyperglycemia by subcutaneously applied insulin after initiation of oral intake in the ICU is going to be investigated.MedDRA version: 9.1Level: LLTClassification code 10042216Term: Stress induced hyperglycemiaEUCTR2007-002773-30-ATHerz-, Thorax- und Gefäßchirurgische Anästhesie und Intensivmedizin
尚未招募
不适用
Insulin Pumps at Diagnosis (IPAD) in children studyType 1 DiabetesACTRN12622000500752Dr Stephanie Johnson80
已完成
3 期
Glucose control through a bihormonal artificial pancreas in patients after total pancreatectomy for cancer (PANORAMA): multicenter randomized controlled cross-over trial - Dutch Pancreatic Cancer Group (DPCG)10018424diabetesNL-OMON53782Amsterdam UMC40